Single Amino Acid Polymorphism at Position 1709 Alters Integrin Beta 4 Function in BT-549 Breast Cancer Cell Growth
Overview
Breast cancer is a leading cause of cancer death around the world; However, Black women are disproportionately affected as they are more likely to develop triple negative breast cancer and have higher mortality rates overall. A single amino acid polymorphism (SNP) was found at the 1709 amino acid position of Integrin Beta 4 (ITGB4), a protein that enhances cancer cell proliferation. At 1709, African populations often have proline, while Europeans have leucine. This study aims to determine whether this SNP affects breast cancer cell growth and ITGB4 function. It was hypothesized that proline cells would have higher growth and ITGB4 expression. MTT assay, TIRF Microscopy, and Phylogeny were conducted to examine the significance of this SNP. First, cells of 1709 proline (1709P), 1709 leucine (1709L), and an Empty Vector were cultured. Cell proliferation rates were measured through an MTT assay for cell counts. TIRF microscopy was also conducted to visualize ITGB4 expression on the cell surface. Finally, phylogeny of ITGB4 was studied to determine if the 1709 amino acid was evolutionarily conserved. Results showed a significant difference between proline and leucine cell variants. 1709 P displayed higher cell proliferation rates through MTT assay and stronger ß4 expression through TIRF microscopy. The 1709L was evolutionarily conserved, signifying that it is important to Integrin Beta 4 protein function. These results suggest that proline at 1709 enhances cell proliferation speed and increases ITGB4 expression in breast cancer cells, which could help explain the mechanisms causing mortality rates differences between racial populations.
Competition history
- ISEF 2022
Resources
Related projects
CSEF · 2006
The Insulin-like Growth Factor Pathway and Breast Cancer Risk in African-American Women
ISEF · 2025
Temporary Inhibition of "Polo Like Kinase-1" Using the siRNA Technique in Triple-Negative Breast Cancer Cells To Reduce the Expression of Mesenchymal Markers
JSHS · 2025
Temporary inhibition of Polo Like Kinase-1 using the siRNA technique in triple-negative breast cancer cells to reduce the expression of mesenchymal markers
ISEF · 2019
Evaluation of a Rare PMS1 Germline Variant as a Putative Hereditary Breast Cancer Risk Allele
CSEF · 2007
The Effect of Alpha3 Integrin on Neuroblastoma Cell Survival
ISEF · 2024
The Impact of Paclitaxel and Doxorubicin on APC Knockout Cells in Breast Cancer
ISEF · 2014
Overcoming Resistance
ISEF · 2016
Can APOBEC3B Be a Therapeutic Target for Breast Cancer?
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair